ES468241A1 - Un metodo para preparar un peptido - Google Patents
Un metodo para preparar un peptidoInfo
- Publication number
- ES468241A1 ES468241A1 ES468241A ES468241A ES468241A1 ES 468241 A1 ES468241 A1 ES 468241A1 ES 468241 A ES468241 A ES 468241A ES 468241 A ES468241 A ES 468241A ES 468241 A1 ES468241 A1 ES 468241A1
- Authority
- ES
- Spain
- Prior art keywords
- phenylalanine
- group
- cysteine
- tryptophan
- threonine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 229940088597 hormone Drugs 0.000 title 1
- 239000005556 hormone Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 229940024606 amino acid Drugs 0.000 abstract 4
- 235000001014 amino acid Nutrition 0.000 abstract 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Chemical group CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 abstract 2
- 239000004473 Threonine Chemical group 0.000 abstract 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 2
- 239000011347 resin Substances 0.000 abstract 2
- 229920005989 resin Polymers 0.000 abstract 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 abstract 1
- 229930182827 D-tryptophan Chemical group 0.000 abstract 1
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical group C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 abstract 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical group C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract 1
- -1 amino acid ester Chemical class 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 229960001230 asparagine Drugs 0.000 abstract 1
- 235000009582 asparagine Nutrition 0.000 abstract 1
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 abstract 1
- 230000008878 coupling Effects 0.000 abstract 1
- 238000010168 coupling process Methods 0.000 abstract 1
- 238000005859 coupling reaction Methods 0.000 abstract 1
- 235000018417 cysteine Nutrition 0.000 abstract 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 abstract 1
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 abstract 1
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/16—Somatostatin; related peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/781,580 US4105603A (en) | 1977-03-28 | 1977-03-28 | Peptides which effect release of hormones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES468241A1 true ES468241A1 (es) | 1978-12-01 |
Family
ID=25123228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES468241A Expired ES468241A1 (es) | 1977-03-28 | 1978-03-27 | Un metodo para preparar un peptido |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4105603A (esLanguage) |
| JP (1) | JPS53130687A (esLanguage) |
| AT (1) | AT366026B (esLanguage) |
| AU (1) | AU519122B2 (esLanguage) |
| BE (1) | BE865380A (esLanguage) |
| CA (1) | CA1102314A (esLanguage) |
| CH (1) | CH639361A5 (esLanguage) |
| DE (1) | DE2813327A1 (esLanguage) |
| DK (1) | DK131878A (esLanguage) |
| ES (1) | ES468241A1 (esLanguage) |
| FI (1) | FI780907A7 (esLanguage) |
| FR (1) | FR2385688A1 (esLanguage) |
| GB (1) | GB1564191A (esLanguage) |
| IE (1) | IE46862B1 (esLanguage) |
| IT (1) | IT1105152B (esLanguage) |
| LU (1) | LU79320A1 (esLanguage) |
| NL (1) | NL7803289A (esLanguage) |
| SE (1) | SE446190B (esLanguage) |
| ZA (1) | ZA781599B (esLanguage) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4211693A (en) * | 1977-09-20 | 1980-07-08 | The Salk Institute For Biological Studies | Peptides with para-substituted phenylalanine |
| US4185010A (en) * | 1978-12-12 | 1980-01-22 | American Home Products Corporation | Nonapeptides |
| US4225472A (en) * | 1979-05-29 | 1980-09-30 | American Home Products Corporation | Truncated somatostatin analogs |
| USRE30548E (en) * | 1979-08-31 | 1981-03-17 | The Salk Institute For Biological Studies | Peptides which effect release of hormones |
| ATE2512T1 (de) * | 1979-11-27 | 1983-03-15 | Sandoz Ag | Polypeptide, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen, die diese polypeptide enthalten, und ihre verwendung. |
| FR2523125A1 (fr) * | 1982-03-08 | 1983-09-16 | Sanofi Sa | Analogues de la somatostatine a activite biologique modifiee et medicaments en contenant |
| US4428942A (en) | 1982-05-17 | 1984-01-31 | The Salk Institute For Biological Studies | Analogs of somatostatin |
| US4443368A (en) * | 1982-11-01 | 1984-04-17 | The Salk Institute For Biological Studies | Peptides affecting gonadal function |
| US4880778A (en) * | 1986-05-12 | 1989-11-14 | Eastman Kodak Company | Combinations having synergistic growth hormone releasing activity and methods for use thereof |
| US4839344A (en) * | 1987-06-12 | 1989-06-13 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
| US4880777A (en) * | 1987-09-01 | 1989-11-14 | Eastman Kodak Company | Synthetic peptides having growth hormone releasing activity |
| WO1989007110A1 (en) * | 1988-01-28 | 1989-08-10 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
| US6737408B1 (en) | 1997-08-07 | 2004-05-18 | University Of Cincinnati | Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm |
| CA2380633A1 (en) * | 1999-08-06 | 2001-02-15 | Genentech, Inc. | Peptide antagonists of factor viia |
| EP1757311B1 (en) | 1999-12-24 | 2009-02-11 | Genentech, Inc. | Methods and compositions for prolonging elimination half-times of bioactive compounds |
| US20060228364A1 (en) * | 1999-12-24 | 2006-10-12 | Genentech, Inc. | Serum albumin binding peptides for tumor targeting |
| US20050287153A1 (en) * | 2002-06-28 | 2005-12-29 | Genentech, Inc. | Serum albumin binding peptides for tumor targeting |
| ATE422369T1 (de) * | 1999-12-24 | 2009-02-15 | Genentech Inc | Verfahren und zusammensetzungen zur verlängerung der entsorgungshalbwertszeit von biowirksamen verbindungen |
| US20040001827A1 (en) * | 2002-06-28 | 2004-01-01 | Dennis Mark S. | Serum albumin binding peptides for tumor targeting |
| US7164002B2 (en) | 2002-02-06 | 2007-01-16 | Genentech, Inc. | FVIIa antagonists |
| JP4621674B2 (ja) * | 2003-09-18 | 2011-01-26 | レイベン バイオテクノロジーズ，インコーポレイティド | Ｋｉｄ３およびｋｉｄ３に結合するｋｉｄ３抗体 |
| JP4390568B2 (ja) * | 2004-01-19 | 2009-12-24 | 富士通株式会社 | 遅延測定システム |
| EP1765868B1 (en) * | 2004-06-07 | 2016-04-20 | MacroGenics, Inc. | Transferrin receptor antibodies |
| MX2007003907A (es) * | 2004-10-05 | 2007-05-21 | Genentech Inc | Agentes terapeuticos con toxicidad reducida. |
| CA2593786A1 (en) | 2005-01-12 | 2006-07-20 | Raven Biotechnologies, Inc. | Kid31 and antibodies that bind thereto |
| CA2596115A1 (en) * | 2005-01-31 | 2006-08-10 | Raven Biotechnologies, Inc. | Luca2 and antibodies that bind thereto |
| CA2596273C (en) | 2005-02-02 | 2017-11-14 | Raven Biotechnologies, Inc. | Adam-9 modulators |
| WO2006084078A2 (en) * | 2005-02-02 | 2006-08-10 | Raven Biotechnologies, Inc. | Jam-3 and antibodies that bind thereto |
| WO2006084092A2 (en) | 2005-02-03 | 2006-08-10 | Raven Biotechnologies, Inc. | Antibodies to oncostatin m receptor |
| US20070197445A1 (en) * | 2006-01-18 | 2007-08-23 | University Of Cincinnati | Compounds for control of appetite |
| EP2094307A4 (en) | 2006-11-08 | 2015-08-26 | Macrogenics West Inc | TES7 AND THEREO BINDING ANTIBODIES |
| WO2010123947A2 (en) | 2009-04-20 | 2010-10-28 | Allergan, Inc. | Silk fibroin hydrogels and uses thereof |
| PL219569B1 (pl) | 2010-02-19 | 2015-05-29 | Peptaderm Spółka Z Ograniczoną Odpowiedzialnością | Cykliczne tetrapeptydy i ich zastosowanie |
| LT2542256T (lt) | 2010-03-04 | 2019-10-25 | Macrogenics Inc | Su b7-h3 reaguojantys antikūnai, jų imunologiškai aktyvūs fragmentai ir jų naudojimas |
| PH12012501751A1 (en) | 2010-03-04 | 2012-11-12 | Macrogenics Inc | Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof |
| MY173899A (en) | 2011-05-21 | 2020-02-26 | Macrogenics Inc | Cd3-binding molecules capable of binding to human and non-human cd3 |
| EP2748182B1 (en) | 2011-08-23 | 2016-10-19 | President and Fellows of Harvard College | Peptide nanoparticles and uses thereof |
| US9487587B2 (en) | 2013-03-05 | 2016-11-08 | Macrogenics, Inc. | Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof |
| LT2968520T (lt) | 2013-03-14 | 2021-09-27 | Macrogenics, Inc. | Bispecifinės molekulės, kurios yra imunoreaktyvios imuninių efektorių ląstelėms, kurios ekspresuoja aktyvuojantį receptorių |
| EP2978438A1 (en) | 2013-03-29 | 2016-02-03 | Centre National de la Recherche Scientifique (C.N.R.S.) | Cgrp receptor agonist for hiv treatment or prevention |
| AP2016009586A0 (en) | 2014-05-29 | 2016-11-30 | Macrogenics Inc | Tri-specific binding molecules and methods of use thereof |
| MX386297B (es) | 2014-09-29 | 2025-03-18 | Univ Duke | Moleculas biespecificas que comprenden un brazo orientado a la envoltura vih-1. |
| TWI688572B (zh) | 2015-01-26 | 2020-03-21 | 美商宏觀基因股份有限公司 | 包含dr5-結合結構域的多價分子 |
| TWI773646B (zh) | 2015-06-08 | 2022-08-11 | 美商宏觀基因股份有限公司 | 結合lag-3的分子和其使用方法 |
| GEAP202215554A (en) | 2015-07-30 | 2022-06-10 | Macrogenics Inc | Pd-1-binding molecules and methods of use thereof |
| AU2016334041B2 (en) | 2015-10-08 | 2023-02-09 | Macrogenics, Inc. | Combination therapy for the treatment of cancer |
| EP3383908A1 (en) | 2015-12-02 | 2018-10-10 | Stsciences, Inc. | Antibodies specific to glycosylated btla (b- and t- lymphocyte attenuator) |
| MX2018007089A (es) | 2015-12-14 | 2019-01-30 | Macrogenics Inc | Moleculas biespecificas que tienen inmunorreactividad con pd-1 y ctla-4, y metodos de uso de las mismas. |
| CA3020864A1 (en) | 2016-04-15 | 2017-10-19 | Macrogenics, Inc. | Novel b7-h3-binding molecules, antibody drug conjugates thereof and methods of use thereof |
| US10111929B1 (en) | 2017-04-07 | 2018-10-30 | Ez Ip, Llc | Growth hormone releasing factor analogs and uses |
| KR20220088428A (ko) | 2019-09-26 | 2022-06-27 | 주식회사 에스티큐브앤컴퍼니 | 글리코실화된 ctla-4에 대해 특이적인 항체 및 이의 사용 방법 |
| CN114829404B (zh) | 2019-10-09 | 2025-09-09 | 斯特库比公司 | 对糖基化的lag3特异的抗体及其使用方法 |
| US11596665B2 (en) | 2020-06-23 | 2023-03-07 | Chanda Zaveri | Skin lightening formulations |
| US11951203B2 (en) | 2020-08-26 | 2024-04-09 | Chanda Zaveri | Deep wrinkle vanishing compositions |
| US11793746B2 (en) | 2020-10-01 | 2023-10-24 | Chanda Zaveri | Intense skin hydration systems and methods |
| US20220110852A1 (en) | 2020-10-14 | 2022-04-14 | Chanda Zaveri | Pigment Stabilizers |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3904594A (en) * | 1973-07-02 | 1975-09-09 | Salk Inst For Biological Studi | Somatostatin and acylated des-(ala' 1', gly' 2') derivatives thereof |
| US3842067A (en) * | 1973-07-27 | 1974-10-15 | American Home Prod | Synthesis of(des-asn5)-srif and intermediates |
| US3917578A (en) * | 1973-12-10 | 1975-11-04 | Ayerst Mckenna & Harrison | Process for producing somatostatin and intermediates |
| US3882098A (en) * | 1974-01-03 | 1975-05-06 | American Home Prod | Synthesis of des-Ala{hu 1{b , Gly{hu 2{b , Asn{hu 5{b -SRIF and intermediates |
| US4011207A (en) * | 1974-12-27 | 1977-03-08 | American Home Products Corporation | Des-(Ala1, Gly2,Lys4 -Srif, Des-(Ala1, Gly2, Lys4)-D-Trp8 -Srif and intermediates |
| US3933784A (en) * | 1975-01-27 | 1976-01-20 | American Home Products Corporation | Des-(ser13)-srif and intermediates |
-
1977
- 1977-03-28 US US05/781,580 patent/US4105603A/en not_active Expired - Lifetime
-
1978
- 1978-03-13 CA CA298,777A patent/CA1102314A/en not_active Expired
- 1978-03-14 IE IE511/78A patent/IE46862B1/en unknown
- 1978-03-17 GB GB10712/78A patent/GB1564191A/en not_active Expired
- 1978-03-20 ZA ZA00781599A patent/ZA781599B/xx unknown
- 1978-03-20 AU AU34307/78A patent/AU519122B2/en not_active Expired
- 1978-03-22 SE SE7803318A patent/SE446190B/sv not_active IP Right Cessation
- 1978-03-22 DK DK131878A patent/DK131878A/da not_active Application Discontinuation
- 1978-03-22 FI FI780907A patent/FI780907A7/fi not_active Application Discontinuation
- 1978-03-23 IT IT48586/78A patent/IT1105152B/it active
- 1978-03-24 AT AT0213878A patent/AT366026B/de not_active IP Right Cessation
- 1978-03-27 ES ES468241A patent/ES468241A1/es not_active Expired
- 1978-03-28 DE DE19782813327 patent/DE2813327A1/de active Granted
- 1978-03-28 NL NL7803289A patent/NL7803289A/xx not_active Application Discontinuation
- 1978-03-28 LU LU79320A patent/LU79320A1/xx unknown
- 1978-03-28 FR FR7808850A patent/FR2385688A1/fr active Granted
- 1978-03-28 BE BE186325A patent/BE865380A/xx not_active IP Right Cessation
- 1978-03-28 JP JP3591778A patent/JPS53130687A/ja active Granted
- 1978-03-28 CH CH330078A patent/CH639361A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS53130687A (en) | 1978-11-14 |
| BE865380A (fr) | 1978-07-17 |
| CH639361A5 (de) | 1983-11-15 |
| FR2385688B1 (esLanguage) | 1983-10-07 |
| IT7848586A0 (it) | 1978-03-23 |
| IE46862B1 (en) | 1983-10-19 |
| NL7803289A (nl) | 1978-10-02 |
| ZA781599B (en) | 1979-10-31 |
| JPS6141920B2 (esLanguage) | 1986-09-18 |
| AT366026B (de) | 1982-03-10 |
| SE446190B (sv) | 1986-08-18 |
| ATA213878A (de) | 1981-07-15 |
| US4105603A (en) | 1978-08-08 |
| FR2385688A1 (fr) | 1978-10-27 |
| CA1102314A (en) | 1981-06-02 |
| IE780511L (en) | 1978-09-28 |
| SE7803318L (sv) | 1978-09-29 |
| DK131878A (da) | 1978-09-29 |
| AU3430778A (en) | 1979-09-27 |
| FI780907A7 (fi) | 1978-09-29 |
| DE2813327A1 (de) | 1978-10-05 |
| IT1105152B (it) | 1985-10-28 |
| DE2813327C2 (esLanguage) | 1988-08-18 |
| LU79320A1 (fr) | 1978-06-29 |
| AU519122B2 (en) | 1981-11-12 |
| GB1564191A (en) | 1980-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES468241A1 (es) | Un metodo para preparar un peptido | |
| KR840009069A (ko) | 향정신성 펩티드류의 제조 방법 | |
| JPS5411294A (en) | Recovery of protease | |
| JPS5232999A (en) | Process for preparing unsaturated epoxy esters having improved curabil ity | |
| DE3166501D1 (en) | Process for the preparation of reactive thyroid gland hormones t3 and t4 derivatives that are capable of coupling, and their use | |
| JPS51151391A (en) | Process for preparing l-sulfur- containing amino acids | |
| JPS5711950A (en) | Peptide and its synthesis | |
| DK117883A (da) | Fremgangsmaade til fremstilling af insuliner ud fra praeproinsulinanaloge | |
| JPS52112648A (en) | Stabilized synthetic resin composition | |
| JPS5411293A (en) | Recovery of protease | |
| ATE17359T1 (de) | Verfahren zur herstellung eines cyklischen hexapeptids. | |
| ES435955A1 (es) | Un procedimiento para obtener un derivado de pirido (3,4-d) piridezina. | |
| JPS5245349A (en) | Holding process for cementing plural lenses | |
| ATE15209T1 (de) | Verfahren zur herstellung von carbonsaeureamidgruppen enthaltenden verbindungen, insbesondere von peptiden. | |
| JPS51113870A (en) | A process for secretin synthesis | |
| GB1178329A (en) | N-[delta-(6-Purinylthio) Valeryl] Amino Acids and derivatives thereof, and a method of producing the same | |
| JPS5264778A (en) | Removing method for clogging powder of pneumatic powder supplier | |
| ATE3296T1 (de) | Verfahren zur herstellung von ergotamin und alkaloiden der ergotoxin-gruppe. | |
| NL7603471A (nl) | Werkwijze ter bereiding van (alpha)-aminozuren. | |
| JPS521091A (en) | Process for preparing amino acids | |
| JPS52139059A (en) | Vinyl process for preparation of n- acyltetra peptides | |
| JPS521093A (en) | Process for preparing amino acids | |
| JPS5212884A (en) | Cylindrical abrasion tester for cylinders | |
| JPS5215595A (en) | Process for preparing an amino resin essentially free from free formal dehyde | |
| JPS5378290A (en) | Prepatation of curable resin for coating |